Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Chronic pain in adults with sickle cell disease is associated with alterations in functional connectivity of the brain.

Karafin MS, Chen G, Wandersee NJ, Brandow AM, Hurley RW, Simpson P, Ward D, Li SJ, Field JJ.

PLoS One. 2019 May 20;14(5):e0216994. doi: 10.1371/journal.pone.0216994. eCollection 2019.

2.

Fluorescent coherent diffractive imaging with accelerating light sheets.

Field JJ, Squier JA, Bartels RA.

Opt Express. 2019 Apr 29;27(9):13015-13030. doi: 10.1364/OE.27.013015.

PMID:
31052833
3.

Synthesis of Bioactive Side-Chain Analogues of TAN-2483B.

Somarathne KK, McCone JAJ, Brackovic A, Rivera JLP, Fulton JR, Russell E, Field JJ, Orme CL, Stirrat HL, Riesterer J, Teesdale-Spittle PH, Miller JH, Harvey JE.

Chem Asian J. 2019 Apr 15;14(8):1230-1237. doi: 10.1002/asia.201801767. Epub 2019 Jan 29.

PMID:
30618187
4.

Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks-American Pain Society-American Academy of Pain Medicine Pain Taxonomy Diagnostic Criteria for Acute Sickle Cell Disease Pain.

Field JJ, Ballas SK, Campbell CM, Crosby LE, Dampier C, Darbari DS, McClish DK, Smith WR, Zempsky WT.

J Pain. 2018 Dec 19. pii: S1526-5900(18)31017-4. doi: 10.1016/j.jpain.2018.12.003. [Epub ahead of print]

PMID:
30578848
5.

Synthesis and Microtubule-Destabilizing Activity of N-Cyclopropyl-4-((3,4-dihydroquinolin-1(2H)-yl)sulfonyl)benzamide and its Analogs.

Field JJ, Singh AJ, Sinha S, Rowe MR, Denny WA, Brooke DG, Miller JH.

Chem Asian J. 2019 Apr 15;14(8):1151-1157. doi: 10.1002/asia.201801313. Epub 2018 Nov 14.

PMID:
30311418
6.

The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease.

Karafin MS, Fu X, D'Alessandro A, Thomas T, Hod EA, Zimring JC, Field JJ, Francis RO.

Curr Opin Hematol. 2018 Nov;25(6):494-499. doi: 10.1097/MOH.0000000000000455.

PMID:
30239377
7.

Peloruside E (22-Norpeloruside A), a Pelorusane Macrolide from the New Zealand Marine Sponge Mycale hentscheli, Retains Microtubule-Stabilizing Properties.

Hong SW, Singh AJ, Patel V, Russell ER, Field JJ, Miller JH, Northcote PT.

J Nat Prod. 2018 Sep 28;81(9):2125-2128. doi: 10.1021/acs.jnatprod.8b00557. Epub 2018 Sep 6.

PMID:
30188708
8.

Induction of antiinflammatory purinergic signaling in activated human iNKT cells.

Yu JC, Lin G, Field JJ, Linden J.

JCI Insight. 2018 Sep 6;3(17). pii: 91954. doi: 10.1172/jci.insight.91954. eCollection 2018 Sep 6.

9.

Three-dimensional single-pixel imaging of incoherent light with spatiotemporally modulated illumination.

Field JJ, Wernsing KA, Squier JA, Bartels RA.

J Opt Soc Am A Opt Image Sci Vis. 2018 Aug 1;35(8):1438-1449. doi: 10.1364/JOSAA.35.001438.

10.

Predictive factors of daily opioid use and quality of life in adults with sickle cell disease.

Karafin MS, Singavi A, Hussain J, Wandersee N, Heinrich T, Hurley RW, Zhang L, Simpson P, Field JJ.

Hematology. 2018 Dec;23(10):856-863. doi: 10.1080/10245332.2018.1479997. Epub 2018 May 31.

PMID:
29848208
11.

Marine Invertebrate Natural Products that Target Microtubules.

Miller JH, Field JJ, Kanakkanthara A, Owen JG, Singh AJ, Northcote PT.

J Nat Prod. 2018 Mar 23;81(3):691-702. doi: 10.1021/acs.jnatprod.7b00964. Epub 2018 Feb 12. Review.

PMID:
29431439
12.

Dyspareunia is associated with chronic pain in premenopausal women with sickle cell disease.

Karafin MS, Singh M, Ceesay M, Koduri S, Zhang L, Simpson P, Field JJ.

Hematology. 2018 Sep;23(8):531-536. doi: 10.1080/10245332.2018.1430521. Epub 2018 Jan 29.

PMID:
29376481
13.

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System.

Fixman BB, Babcock IW, Minamide LS, Shaw AE, Oliveira da Silva MI, Runyan AM, Maloney MT, Field JJ, Bamburg JR.

J Vis Exp. 2017 Dec 28;(130). doi: 10.3791/56436.

14.

Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease.

Mehrad B, Burdick MD, Wandersee NJ, Shahir KS, Zhang L, Simpson PM, Strieter RM, Field JJ.

Blood Adv. 2017 Nov 6;1(24):2217-2224. doi: 10.1182/bloodadvances.2017010777. eCollection 2017 Nov 14.

15.

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.

Field JJ, Majerus E, Gordeuk VR, Gowhari M, Hoppe C, Heeney MM, Achebe M, George A, Chu H, Sheehan B, Puligandla M, Neuberg D, Lin G, Linden J, Nathan DG.

Blood Adv. 2017 Aug 28;1(20):1645-1649. doi: 10.1182/bloodadvances.2017009613. eCollection 2017 Sep 12. Erratum in: Blood Adv. 2017 Oct 19;1(23 ):2058.

16.

Five lessons learned about long-term pain management in adults with sickle cell disease.

Field JJ.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):406-411. doi: 10.1182/asheducation-2017.1.406. Review.

17.

Single pixel quantitative phase imaging with spatial frequency projections.

Stockton PA, Field JJ, Bartels RA.

Methods. 2018 Mar 1;136:24-34. doi: 10.1016/j.ymeth.2017.10.007. Epub 2017 Oct 26.

PMID:
29107101
18.

Zampanolide Binding to Tubulin Indicates Cross-Talk of Taxane Site with Colchicine and Nucleotide Sites.

Field JJ, Pera B, Gallego JE, Calvo E, Rodríguez-Salarichs J, Sáez-Calvo G, Zuwerra D, Jordi M, Andreu JM, Prota AE, Ménchon G, Miller JH, Altmann KH, Díaz JF.

J Nat Prod. 2018 Mar 23;81(3):494-505. doi: 10.1021/acs.jnatprod.7b00704. Epub 2017 Oct 12.

PMID:
29023132
19.

Opioid management strategy decreases admissions in high-utilizing adults with sickle cell disease.

Mager A, Pelot K, Koch K, Miller L, Hubler C, Ndifor A, Coan C, Leonard C, Field JJ.

J Opioid Manag. 2017 May/Jun;13(3):143-156. doi: 10.5055/jom.2017.0382.

PMID:
28829516
20.

Airway Hyperresponsiveness Does Not Predict Morbidity in Children with Sickle Cell Anemia.

Willen SM, Rodeghier M, Strunk RC, Rosen CL, Kirkham FJ, Field JJ, DeBaun MR, Cohen RT.

Am J Respir Crit Care Med. 2017 Jun 1;195(11):1533-1534. doi: 10.1164/rccm.201610-1970LE. No abstract available.

21.

Zampanolide, a Microtubule-Stabilizing Agent, Is Active in Resistant Cancer Cells and Inhibits Cell Migration.

Field JJ, Northcote PT, Paterson I, Altmann KH, Díaz JF, Miller JH.

Int J Mol Sci. 2017 May 3;18(5). pii: E971. doi: 10.3390/ijms18050971.

22.

A Fatal Case of Immune Hyperhemolysis with Bone Marrow Necrosis in a Patient with Sickle Cell Disease.

Karafin MS, Singavi A, Johnson ST, Field JJ.

Hematol Rep. 2017 Mar 1;9(1):6934. doi: 10.4081/hr.2017.6934. eCollection 2017 Feb 23.

23.

Older red cell units are associated with an increased incidence of infection in chronically transfused adults with sickle cell disease.

Karafin MS, Carpenter E, Pan A, Simpson P, Field JJ.

Transfus Apher Sci. 2017 Jun;56(3):345-351. doi: 10.1016/j.transci.2017.01.008. Epub 2017 Feb 9.

PMID:
28279592
24.

Use of substitute Nonidet P-40 nonionic detergents in intracellular tubulin polymerization assays for screening of microtubule targeting agents.

Sinha S, Field JJ, Miller JH.

Biochem Cell Biol. 2017 Jun;95(3):379-384. doi: 10.1139/bcb-2016-0141. Epub 2017 Jan 10.

PMID:
28177759
25.

NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease.

Field JJ, Majerus E, Ataga KI, Vichinsky EP, Schaub R, Mashal R, Nathan DG.

PLoS One. 2017 Feb 2;12(2):e0171067. doi: 10.1371/journal.pone.0171067. eCollection 2017.

26.

Superresolved multiphoton microscopy with spatial frequency-modulated imaging.

Field JJ, Wernsing KA, Domingue SR, Allende Motz AM, DeLuca KF, Levi DH, DeLuca JG, Young MD, Squier JA, Bartels RA.

Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):6605-10. doi: 10.1073/pnas.1602811113. Epub 2016 May 26.

27.

A pragmatic guide to multiphoton microscope design.

Young MD, Field JJ, Sheetz KE, Bartels RA, Squier J.

Adv Opt Photonics. 2015 Jun 30;7(2):276-378.

28.

Synthesis of a simplified triazole analogue of pateamine A.

Hemi Cumming A, Brown SL, Tao X, Cuyamendous C, Field JJ, Miller JH, Harvey JE, Teesdale-Spittle PH.

Org Biomol Chem. 2016 Jun 14;14(22):5117-27. doi: 10.1039/c6ob00086j. Epub 2016 May 16.

29.

Microtubule-stabilizing properties of the avocado-derived toxins (+)-(R)-persin and (+)-(R)-tetrahydropersin in cancer cells and activity of related synthetic analogs.

Field JJ, Kanakkanthara A, Brooke DG, Sinha S, Pillai SD, Denny WA, Butt AJ, Miller JH.

Invest New Drugs. 2016 Jun;34(3):277-89. doi: 10.1007/s10637-016-0341-z. Epub 2016 Mar 12.

PMID:
26968704
30.

Maternal opioid dose is associated with neonatal abstinence syndrome in children born to women with sickle cell disease.

Shirel T, Hubler CP, Shah R, Mager AB, Koch KL, Sheth D, Uhing MR, Jones CW, Field JJ.

Am J Hematol. 2016 Jun;91(4):416-9. doi: 10.1002/ajh.24307.

31.

Red cell storage age policy for patients with sickle cell disease: A survey of transfusion service directors in the United States.

Karafin MS, Singavi AK, Irani MS, Puca KE, Baumann Kreuziger L, Simpson P, Field JJ.

Transfus Apher Sci. 2016 Feb;54(1):158-62. doi: 10.1016/j.transci.2015.12.001. Epub 2015 Dec 23.

PMID:
26775259
32.

Simultaneous spatial frequency modulation imaging and micromachining with a femtosecond laser.

Block E, Young MD, Winters DG, Field JJ, Bartels RA, Squier JA.

Opt Lett. 2016 Jan 15;41(2):265-8. doi: 10.1364/OL.41.000265.

33.

Polyhalogenated Indoles from the Red Alga Rhodophyllis membranacea: The First Isolation of Bromo-Chloro-Iodo Secondary Metabolites.

Woolner VH, Jones CM, Field JJ, Fadzilah NH, Munkacsi AB, Miller JH, Keyzers RA, Northcote PT.

J Nat Prod. 2016 Mar 25;79(3):463-9. doi: 10.1021/acs.jnatprod.5b00831. Epub 2016 Jan 12.

PMID:
26756908
34.

Sickle solubility test to screen for sickle cell trait: what's the harm?

Tubman VN, Field JJ.

Hematology Am Soc Hematol Educ Program. 2015;2015:433-5. doi: 10.1182/asheducation-2015.1.433. Review. No abstract available.

PMID:
26637754
35.

Can selectin and iNKT cell therapies meet the needs of people with sickle cell disease?

Field JJ.

Hematology Am Soc Hematol Educ Program. 2015;2015:426-32. doi: 10.1182/asheducation-2015.1.426.

PMID:
26637753
36.

Plane wave analysis of coherent holographic image reconstruction by phase transfer (CHIRPT).

Field JJ, Winters DG, Bartels RA.

J Opt Soc Am A Opt Image Sci Vis. 2015 Nov 1;32(11):2156-68. doi: 10.1364/JOSAA.32.002156.

PMID:
26560930
37.

Erythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease.

Karafin MS, Koch KL, Rankin AB, Nischik D, Rahhal G, Simpson P, Field JJ.

Blood Cells Mol Dis. 2015 Dec;55(4):304-7. doi: 10.1016/j.bcmd.2015.07.010. Epub 2015 Jul 17.

38.

Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia.

Karafin MS, Dogra S, Rodeghier M, Burdick M, Mehrad B, Rose CE, Strieter RM, DeBaun MR, Strunk RC, Field JJ.

Pediatr Pulmonol. 2016 Mar;51(3):295-9. doi: 10.1002/ppul.23248. Epub 2015 Jun 30.

39.

A case of acute chest syndrome complicated by diffuse cerebral infarcts in an adult with HbSβ-thalassemia(.).

Chandran R, Moran A, Barash M, Hopper B, Rankin A, Field JJ.

Am J Hematol. 2015 Sep;90(9):E197. doi: 10.1002/ajh.24090. Epub 2015 Aug 14. No abstract available.

40.

Ultra-large field-of-view two-photon microscopy.

Tsai PS, Mateo C, Field JJ, Schaffer CB, Anderson ME, Kleinfeld D.

Opt Express. 2015 Jun 1;23(11):13833-47. doi: 10.1364/OE.23.013833.

41.

βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.

Kanakkanthara A, Rowe MR, Field JJ, Northcote PT, Teesdale-Spittle PH, Miller JH.

Cancer Lett. 2015 Sep 1;365(2):251-60. doi: 10.1016/j.canlet.2015.06.001. Epub 2015 Jun 4.

PMID:
26052091
42.

NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology.

Karafin MS, Sachais BS, Connelly-Smith L, Field JJ, Linenberger ML, Padmanabhan A.

J Clin Apher. 2016 Feb;31(1):38-47. doi: 10.1002/jca.21400. Epub 2015 May 4.

PMID:
25940408
43.

Synthesis of mycothiol conjugate analogues and evaluation of their antimycobacterial activity.

Riordan SW, Field JJ, Corkran HM, Dasyam N, Stocker BL, Timmer MS, Harvey JE, Teesdale-Spittle PH.

Bioorg Med Chem Lett. 2015;25(10):2152-5. doi: 10.1016/j.bmcl.2015.03.070. Epub 2015 Mar 31.

PMID:
25881831
44.

Use of a dual lumen port for automated red cell exchange in adults with sickle cell disease.

Shrestha A, Jawa Z, Koch KL, Rankin AB, Xiang Q, Padmanabhan A, Karafin MS, Field JJ.

J Clin Apher. 2015 Dec;30(6):353-8. doi: 10.1002/jca.21393. Epub 2015 Mar 19.

PMID:
25790325
45.

Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.

Karafin MS, Field JJ, Gottschall JL, Denomme GA.

Transfusion. 2015 Jun;55(6 Pt 2):1399-406. doi: 10.1111/trf.13037. Epub 2015 Mar 9.

PMID:
25757390
46.

Advances in sickle cell therapies in the hydroxyurea era.

Field JJ, Nathan DG.

Mol Med. 2014 Dec 16;20 Suppl 1:S37-42. doi: 10.2119/molmed.2014.00187. Review.

47.

Intensive management of high-utilizing adults with sickle cell disease lowers admissions.

Koch KL, Karafin MS, Simpson P, Field JJ.

Am J Hematol. 2015 Mar;90(3):215-9. doi: 10.1002/ajh.23912. Epub 2015 Jan 16.

48.

The Nitrogenous Hamigerans: Unusual Amino Acid-Derivatized Aromatic Diterpenoid Metabolites from the New Zealand Marine Sponge Hamigera tarangaensis.

Dattelbaum JD, Singh AJ, Field JJ, Miller JH, Northcote PT.

J Org Chem. 2015 Jan 2;80(1):304-12. doi: 10.1021/jo502370b. Epub 2014 Dec 4.

PMID:
25423500
49.

A previously undescribed tubulin binder.

Field JJ, Waight AB, Senter PD.

Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):13684-5. doi: 10.1073/pnas.1414572111. Epub 2014 Sep 3. No abstract available.

50.

Sickle cell disease: new treatments and their rationale.

Field JJ.

Clin Adv Hematol Oncol. 2013 Nov;11(11):740-3. Review. No abstract available.

PMID:
24896548

Supplemental Content

Loading ...
Support Center